165 related articles for article (PubMed ID: 2825381)
1. Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks.
Bowden RA; Sayers M; Gleaves CA; Banaji M; Newton B; Meyers JD
Transfusion; 1987; 27(6):478-81. PubMed ID: 2825381
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.
Verdonck LF; de Graan-Hentzen YC; Dekker AW; Mudde GC; de Gast GC
Bone Marrow Transplant; 1987 Jun; 2(1):73-8. PubMed ID: 2844337
[TBL] [Abstract][Full Text] [Related]
3. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors.
De Witte T; Schattenberg A; Van Dijk BA; Galama J; Olthuis H; Van der Meer JW; Kunst VA
Transplantation; 1990 Dec; 50(6):964-8. PubMed ID: 2175059
[TBL] [Abstract][Full Text] [Related]
4. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.
Bowden RA; Slichter SJ; Sayers M; Weisdorf D; Cays M; Schoch G; Banaji M; Haake R; Welk K; Fisher L; McCullough J; Miller W
Blood; 1995 Nov; 86(9):3598-603. PubMed ID: 7579469
[TBL] [Abstract][Full Text] [Related]
5. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant.
Bowden RA; Slichter SJ; Sayers MH; Mori M; Cays MJ; Meyers JD
Blood; 1991 Jul; 78(1):246-50. PubMed ID: 1648976
[TBL] [Abstract][Full Text] [Related]
6. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
Narvios AB; Przepiorka D; Tarrand J; Chan KW; Champlin R; Lichtiger B
Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346
[TBL] [Abstract][Full Text] [Related]
7. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections.
Grob JP; Grundy JE; Prentice HG; Griffiths PD; Hoffbrand AV; Hughes MD; Tate T; Wimperis JZ; Brenner MK
Lancet; 1987 Apr; 1(8536):774-6. PubMed ID: 2882184
[TBL] [Abstract][Full Text] [Related]
8. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening.
Miller WJ; McCullough J; Balfour HH; Haake RJ; Ramsay NK; Goldman A; Bowman R; Kersey J
Bone Marrow Transplant; 1991 Mar; 7(3):227-34. PubMed ID: 1647829
[TBL] [Abstract][Full Text] [Related]
9. Prevention of CMV infection by screening for CMV antibodies in renal allograft recipients and their blood and kidney donors.
Metselaar HJ; Ploeg RJ; Van Loon AM; Weiland HT; Rothbarth PH; Paul LC; Brand A; Schaafsma R; Hendriks GF; Jeekel J
Scand J Infect Dis; 1988; 20(2):135-9. PubMed ID: 2840730
[TBL] [Abstract][Full Text] [Related]
10. Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: a prospective study.
Preiksaitis JK; Desai S; Vaudry W; Roberts S; Akabutu J; Grundy P; Wilson B; Boshkov L; Hannon J; Joffres M
Transfusion; 1997 Sep; 37(9):941-6. PubMed ID: 9308642
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation.
Bowden RA; Sayers M; Flournoy N; Newton B; Banaji M; Thomas ED; Meyers JD
N Engl J Med; 1986 Apr; 314(16):1006-10. PubMed ID: 3007984
[TBL] [Abstract][Full Text] [Related]
12. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters.
van Prooijen HC; Visser JJ; van Oostendorp WR; de Gast GC; Verdonck LF
Br J Haematol; 1994 May; 87(1):144-7. PubMed ID: 7947238
[TBL] [Abstract][Full Text] [Related]
13. Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation.
Mackinnon S; Burnett AK; Crawford RJ; Cameron S; Leask BG; Sommerville RG
J Clin Pathol; 1988 Sep; 41(9):948-50. PubMed ID: 2848062
[TBL] [Abstract][Full Text] [Related]
14. Detection of cytomegalovirus antibody in stored blood products using latex agglutination.
Klinedinst AF; Baldwin ML; Ness PM
Transfusion; 1988; 28(6):563-5. PubMed ID: 2848338
[TBL] [Abstract][Full Text] [Related]
15. Detection of cytomegalovirus antibody with latex agglutination.
Adler SP; McVoy M; Biro VG; Britt WJ; Hider P; Marshall D
J Clin Microbiol; 1985 Jul; 22(1):68-70. PubMed ID: 2991330
[TBL] [Abstract][Full Text] [Related]
16. Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study.
Narvios AB; Lichtiger B
Haematologica; 2001 Jul; 86(7):749-52. PubMed ID: 11454531
[TBL] [Abstract][Full Text] [Related]
17. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.
Yeager AS; Grumet FC; Hafleigh EB; Arvin AM; Bradley JS; Prober CG
J Pediatr; 1981 Feb; 98(2):281-7. PubMed ID: 6257877
[TBL] [Abstract][Full Text] [Related]
18. Prevention of transfusion-associated cytomegalovirus infection in very low-birthweight infants using frozen blood and donors seronegative for cytomegalovirus.
Adler SP; Lawrence LT; Baggett J; Biro V; Sharp DE
Transfusion; 1984; 24(4):333-5. PubMed ID: 6087517
[TBL] [Abstract][Full Text] [Related]
19. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G
Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551
[TBL] [Abstract][Full Text] [Related]
20. Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative.
Smith D; Lu Q; Yuan S; Goldfinger D; Fernando LP; Ziman A
Vox Sang; 2010 Jan; 98(1):29-36. PubMed ID: 19695013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
